Learn how to report adverse drug reactions to the FDA’s MedWatch system. Step-by-step guide for patients and providers on what to report, how to file, and why it matters for drug safety.
Certain medications can trigger dangerous blood clots. Learn how to recognize the signs, who’s at risk, and what steps you can take to prevent them - before it’s too late.
Dechallenge and rechallenge are clinical methods used to determine if a drug caused a side effect. Stopping the drug to see if symptoms improve is dechallenge; restarting it to see if the reaction returns is rechallenge. These steps help doctors confirm causality and prevent future harm.
Learn how to pack medications for air travel safely with TSA-compliant tips for liquids, temperature-sensitive drugs, international rules, and what to do at security. Avoid delays and ruined meds with proven best practices.
Mast cell activation syndrome causes chronic, multi-system symptoms due to uncontrolled release of histamine and other mediators. Mast cell stabilizers like cromolyn sodium can prevent this release, offering relief for many patients - if used correctly and consistently.
Neuroleptic Malignant Syndrome (NMS) is a rare but deadly reaction to antipsychotic and dopamine-blocking medications. Learn the four key symptoms, who's at risk, how it's treated, and why early recognition can mean the difference between life and death.
Missing a medication dose is common, but doubling up to make up for it can be dangerous. Learn safe, science-backed steps to handle missed pills without risking overdose, especially for high-risk drugs like warfarin, methotrexate, and birth control.
Skipping prescription doses can lead to dangerous health risks, drug resistance, and hospitalizations. Learn why timing matters, what happens when you miss a dose, and how to build a reliable routine that keeps you safe.
Mistranslated prescription labels put millions at risk. Learn the most common errors, how they happen, and what you can do to protect yourself or a loved one from dangerous medication mistakes.
The EU's generic drug approval system uses four pathways with varying timelines and costs. The 2025 Pharma Package reforms aim to speed up access, reduce fragmentation, and increase competition-but national differences still create delays.